Mirova Viatris Inc Transaction History

Mirova

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $48,482 - $55,308	-5,375 Reduced 62.43%	3,234 $32,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $240,156 - $320,035	-26,104 Reduced 75.2%	8,609 $82,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $186,163 - $246,794	21,349 Added 159.75%	34,713 $386,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $536,232 - $703,805	-63,235 Reduced 82.55%	13,364 $113,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $547,269 - $674,874	55,002 Added 254.67%	76,599 $801,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $117 - $184	-12 Reduced 0.06%	21,597 $234,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $261,252 - $317,220	21,609 New	21,609 $292,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.